Tumor suppressor miR-424-5p abrogates ferroptosis in ovarian cancer through targeting ACSL4

Lin-Lin Ma1, Lin Liang1, Dan Zhou1

  • 1Department of Gynecology and Obstetrics, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.

Neoplasma
|October 11, 2020
PubMed

Insights

MicroRNA miR-424-5p suppresses ferroptosis in ovarian cancer by targeting ACSL4. This finding reveals a new mechanism for ovarian cancer progression and suggests potential therapeutic strategies targeting microRNAs and ferroptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Ovarian cancer remains a leading cause of gynecological cancer mortality, necessitating novel therapeutic strategies.
  • MicroRNAs (miRNAs) are implicated in ovarian cancer development and progression.
  • Ferroptosis, a form of regulated cell death, acts as a tumor suppressor, but its miRNA-mediated regulation in ovarian cancer is poorly understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms of miRNA-mediated ferroptosis regulation in ovarian cancer.
  • To investigate the role of miR-424-5p in ferroptosis and its direct target in ovarian cancer cells.

Main Methods:

  • Investigated the direct targeting of ACSL4 by miR-424-5p in ovarian cancer cells.
  • Assessed the impact of miR-424-5p modulation on ferroptosis induced by erastin and RSL3.
  • Analyzed ACSL4 expression in ovarian cancer tissues and correlated it with patient prognosis and ferroptosis sensitivity.

Main Results:

  • miR-424-5p directly targets the 3'-UTR of ACSL4, leading to its suppression.
  • Upregulation of miR-424-5p reduced erastin- and RSL3-induced ferroptosis, while its knockdown increased sensitivity.
  • ACSL4 was upregulated in ovarian cancer tissues, associated with poor prognosis, and mediated ferroptosis sensitivity.

Conclusions:

  • miR-424-5p negatively regulates ferroptosis in ovarian cancer by targeting ACSL4.
  • The miR-424-5p/ACSL4 axis represents a novel regulatory pathway in ovarian cancer progression.
  • Targeting this pathway offers a potential therapeutic avenue for ovarian cancer treatment.

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K